Organon invests in Vietnam to transform women's healthcare

According to an Organon's representative, the establishment of this new entity will enhance its ability to serve the Vietnamese market, foster local partnerships, and contribute to the country's healthcare development.

Organon's opening ceremony. Photo courtesy of Organon

Andreas Daugaard Jorgensen, Managing Director of Organon Asia Pacific, said that with more than 2 billion people in this region, they are committed to making a world of difference in women's health every day.

"Vietnam's dynamic market presents a tremendous opportunity for us to contribute to the healthcare sector and improve the lives of many," said Andreas.

Andreas Daugaard Jorgensen, Managing Director of Organon Asia Pacific. Photo courtesy of Organon

Organon's expansion into Vietnam focuses on addressing pressing issues such as declining birth rates and unintended pregnancies.

Cases of unintended pregnancies in Vietnam are still existing, posing significant challenges to women's health and well-being.

These unintended pregnancies often lead to unsafe abortions, contributing to maternal mortality and other severe health complications.

To address these challenges, Organon has signed a Memorandum of Understanding with the Vietnam Population Authority.

This partnership aims to enhance reproductive health and family planing knowledge through new digital resources and a hotline for women aged 19-24 years.

By empowering women with knowledge and resources, Organon strives to reduce unintended pregnancies and promote safer reproductive health practices.

Organon is a global healthcare company with a focus on improving the health of women throughout their lives, with a portfolio of more than 60 medicines and products across a range of therapeutic areas.

Led by the women’s health portfolio coupled with an expanding biosimilars business and a stable franchise of established medicines, its products produce strong cash flows that will support investments in innovation and future growth opportunities in women’s health.

In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast-growing international markets.